PEAK6 Group’s Dr. Reddy's Laboratories RDY Stock Holding History

PEAK6 Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,000	Closed	-$188K	–	4826
2017 Q4	$188K	Sell	25,000 -225,000	-90%	-$1.62M	﹤0.01%	3199
2017 Q3	$1.78M	Buy	+250,000	New	+$1.8M	0.01%	1485
2017 Q1	–	Sell	-38,000	Closed	-$344K	–	4865
2016 Q4	$344K	Sell	38,000 -77,000	-67%	-$717K	﹤0.01%	2862
2016 Q3	$1.07M	Buy	115,000 +106,500	+1,253%	+$1.02M	0.01%	1723
2016 Q2	$87K	Sell	8,500 -234,000	-96%	-$2.14M	﹤0.01%	3649
2016 Q1	$2.19M	Sell	242,500 -78,500	-24%	-$702K	0.02%	1102
2015 Q4	$2.97M	Buy	321,000 +192,000	+149%	+$2.1M	0.02%	1053
2015 Q3	$1.65M	Sell	129,000 -8,500	-6%	-$106K	0.01%	1727
2015 Q2	$1.52M	Buy	+137,500	New	+$1.52M	0.01%	1701
2014 Q4	–	Sell	-29,500	Closed	-$310K	–	5062
2014 Q3	$310K	Hold	29,500	–	–	﹤0.01%	2906
2014 Q2	$255K	Buy	29,500 +18,500	+168%	+$156K	﹤0.01%	2973
2014 Q1	$97K	Sell	11,000 -34,000	-76%	-$296K	﹤0.01%	3963
2013 Q4	$369K	Sell	45,000 -45,000	-50%	-$356K	﹤0.01%	2958
2013 Q3	$340K	Sell	90,000 -80,500	-47%	-$586K	﹤0.01%	3174
2013 Q2	$1.29K	Buy	+170,500	New	+$1.24M	﹤0.01%	1921

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PEAK6 Group's RDY Position: Q1 2018 in Review

PEAK6 Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2018, closing a stake of 4,190 shares — an estimated $31K sold.

PEAK6 Group first reported a position in RDY in Q2 2013 and held it in 11 quarters. The position peaked at $1.55M in Q4 2015. 121 funds tracked by Wall St. Rank hold RDY as of Q1 2018.

PEAK6 Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 4,190 Dr. Reddy's Laboratories shares in Q1 2018, an estimated $31K.
PEAK6 Group first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 11 quarters.
PEAK6 Group's Dr. Reddy's Laboratories position peaked at $1.55M in Q4 2015.
121 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.